We reviewed 888 temporal artery biopsies (TAB) performed in 871 patients in a single institution
from January 1986 to December 2013. Forty-four biopsies (4.9%) were inadequate, 490 …

We conducted a large-scale genetic analysis on giant cell arteritis (GCA), a polygenic
immune-mediated vasculitis. A case-control cohort, comprising 1,651 case subjects with GCA and …

Objective To investigate predictors of response, remission, low disease activity, damage,
and drug discontinuation in patients with systemic lupus erythematosus ( SLE ) who were …

Objective To investigate efficacy, safety and survival of belimumab and to identify predictors
of drug response and drug discontinuation in patients with active SLE in clinical practice. …

Objective. Neutrophil extracellular traps (NET) expose modified antigens for autoantibodies
in vasculitis. Little is known about levels and removal pathways of NET in systemic lupus …

Objective To compare the performance of published classification/diagnostic criteria for
polymyalgia rheumatica (PMR), including the new 2012 European League Against Rheumatism (…

Objectives To describe the response to IL-6 blockade [tocilizumab (TCZ)] in three patients
affected by highly refractory neuro-Behçet disease (NBD). Methods Three patients who had …

Objectives To assess the efficacy and safety of rituximab (RTX) in patients with Takayasu
arteritis (TAK). Methods We conducted a retrospective study on seven TAK patients treated with …

Pregnancy requires a special management in women with inflammatory rheumatic diseases
(RDs), with the aim of controlling maternal disease activity and avoiding fetal complications. …

Background Belimumab was recently approved for treatment of lupus glomerulonephritis (LN).
Aim To evaluate renal response and its predictors in LN patients receiving belimumab in …